Concepedia
Statistics
Publications
5
Citations
133
H-Index
Active since
2017
Affiliations
University of Chinese Academy of Sciences(Current)
Shanghai Institute of Materia Medica
Chinese Academy of Sciences
ShanghaiTech University
Deqiao Sun is an author at University of Chinese Academy of Sciences specializing in pharmacology, medicine, and medicinal chemistry.
Publications per year
2017–2021
Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti–PD-1 Immunotherapy
Wenjie You, Lijun Li, Deqiao Sun et al. · Cancer Immunology Research · 2019 · 48 citations
Medicine, Immunology, Oncology +17
Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
Peng Xia, Pengcong Hou, Yi Chen et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 32 citations · Full text
Medicine, Oncology, Pharmacology +17
Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation
Dandan Xu, Deqiao Sun, Wei Wang et al. · European Journal of Medicinal Chemistry · 2021 · 21 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation
Kaijun Geng, Zongjun Xia, Yinchun Ji et al. · European Journal of Medicinal Chemistry · 2017 · 16 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +13
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors
Zongjun Xia, Yinchun Ji, Deqiao Sun et al. · Acta Pharmacologica Sinica · 2020 · 16 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
1–5 of 5